Your browser doesn't support javascript.
loading
Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate.
Kiyan, Yulia; Schultalbers, Anna; Chernobrivaia, Ekaterina; Tkachuk, Sergey; Rong, Song; Shushakova, Nelli; Haller, Hermann.
Affiliation
  • Kiyan Y; Department of Nephrology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany. kiian.ioulia@mh-hannover.de.
  • Schultalbers A; Department of Nephrology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Chernobrivaia E; Mount Desert Biological Laboratory MDIBL, Bar Harbor, USA.
  • Tkachuk S; Department of Nephrology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Rong S; Department of Nephrology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Shushakova N; Department of Nephrology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
  • Haller H; Phenos GmbH, Hannover, Germany.
Sci Rep ; 12(1): 16878, 2022 10 07.
Article in En | MEDLINE | ID: mdl-36207386

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcium Dobesilate / COVID-19 Drug Treatment Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcium Dobesilate / COVID-19 Drug Treatment Limits: Animals / Humans Language: En Journal: Sci Rep Year: 2022 Document type: Article Affiliation country: Country of publication: